Heterogeneous nuclear ribonucleoprotein F (hnRNP F) is a multifunctional RNA-binding protein involved in various cellular processes, including pre-mRNA processing, mRNA transport, and translation regulation. As a member of the hnRNP family, hnRNP F plays a crucial role in post-transcriptional gene regulation by binding to RNA molecules and modulating their splicing, stability, and localization within the cell. Specifically, hnRNP F is known to interact with specific RNA sequences and splice sites, thereby influencing alternative splicing events and regulating gene expression patterns in a context-dependent manner. Moreover, hnRNP F has been implicated in diverse cellular functions, such as cell proliferation, differentiation, and apoptosis, highlighting its significance in maintaining cellular homeostasis and function.
The activation of hnRNP F involves complex regulatory mechanisms that modulate its RNA-binding activity and functional interactions within the cellular environment. One of the key mechanisms of hnRNP F activation is post-translational modification, including phosphorylation, methylation, and acetylation, which can alter its binding affinity for RNA substrates and affect its subcellular localization and activity. Additionally, hnRNP F activity can be regulated by various signaling pathways and cellular stimuli, such as growth factors, stress signals, and developmental cues, which can induce conformational changes or alter its association with other proteins or RNA molecules. Furthermore, hnRNP F activity may be modulated by the availability of specific RNA targets or by interactions with other RNA-binding proteins, transcription factors, or splicing regulators, forming dynamic regulatory networks that fine-tune gene expression programs in response to changing cellular conditions. Overall, the activation of hnRNP F is intricately regulated by multiple factors and mechanisms, underscoring its importance in diverse cellular processes and biological contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent, non-selective inhibitor of protein kinases. It inhibits several kinases that phosphorylate hnRNP F, such as PKC and PKA. By reducing the phosphorylation of hnRNP F, Staurosporine can potentially enhance the binding affinity of hnRNP F for its target pre-mRNA sequences, thus indirectly activating hnRNP F. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). Activation of PKC can increase the phosphorylation of hnRNP F, modulating its binding to target pre-mRNAs and potentially influencing its activity. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A-769662 is an AMP-activated protein kinase (AMPK) activator. By activating AMPK, A-769662 can trigger downstream signaling events that potentially influence the activity of hnRNP F, such as modulation of mRNA splicing. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor. By inhibiting DNA methylation, 5-Azacytidine can alter gene expression patterns, potentially affecting the expression of hnRNP F and indirectly modulating its activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. By inhibiting histone deacetylase, Trichostatin A can alter chromatin structure and gene expression patterns, which can indirectly influence the expression of hnRNP F and its activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a short-chain fatty acid that acts as an HDAC inhibitor. By inhibiting HDACs, Sodium butyrate can alter chromatin structure and gene expression, potentially influencing the expression of hnRNP F and its activity. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $108.00 $780.00 | 3 | |
Sodium arsenite can induce oxidative stress in cells. Oxidative stress can trigger signaling pathways that potentially modulate the activity of RNA-binding proteins like hnRNP F. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is a glucocorticoid receptor agonist. By activating the glucocorticoid receptor, dexamethasone can alter gene transcription patterns, potentially influencing the expression of hnRNP F and its activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor. By inhibiting the proteasome, MG132 can alter protein stability and turnover, potentially influencing the stability and activity of hnRNP F. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a cyclin-dependent kinase (CDK) inhibitor. By inhibiting CDKs, Roscovitine can modulate cell cycle progression and potentially the activity of cell cycle-regulated RNA-binding proteins like hnRNP F. | ||||||